Stockscreener 앱 받기
2.07
0.00%
0.00
시장 영업 전:
2.14
0.07
+3.38%
전일 마감가:
$2.07
열려 있는:
$2.12
하루 거래량:
1.95M
Relative Volume:
0.11
시가총액:
$262.14M
수익:
-
순이익/손실:
$-112.46M
주가수익비율:
-1.2622
EPS:
-1.64
순현금흐름:
$-99.89M
1주 성능:
-1.43%
1개월 성능:
-13.75%
6개월 성능:
+46.81%
1년 성능:
+149.10%
1일 변동 폭
$2.025
$2.14
1주일 범위
$2.015
$2.27
52주 변동 폭
$0.1311
$3.29
보 바이오파마 Stock (VOR) Company Profile
명칭
Vor Biopharma Inc
전화
617-655-6580
주소
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
VOR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
2.07 | 261.17M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
보 바이오파마 Stock (VOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | 개시 | Wedbush | Outperform |
| 2022-04-27 | 개시 | Goldman | Neutral |
| 2021-12-17 | 개시 | H.C. Wainwright | Buy |
| 2021-12-03 | 개시 | Robert W. Baird | Outperform |
| 2021-12-02 | 개시 | Oppenheimer | Outperform |
| 2021-10-19 | 개시 | JMP Securities | Mkt Outperform |
| 2021-03-25 | 개시 | B. Riley Securities | Buy |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-03-03 | 개시 | Evercore ISI | Outperform |
| 2021-03-02 | 개시 | Goldman | Sell |
| 2021-03-02 | 개시 | Stifel | Buy |
모두보기
보 바이오파마 주식(VOR)의 최신 뉴스
Vor Biopharma Inc. (NASDAQ:VOR) Short Interest Update - MarketBeat
Intraday Charts Show Spike in Vor Biopharma Inc. ActivitySwing Trade Plans Emphasize Risk Management - metal.it
Vor Bio appoints seasoned biotech executive Dallan Murray as Chief Commercial Officer - MarketScreener
Vor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer - GlobeNewswire
What are Vor Biopharma Inc. company’s key revenue driversDynamic investment opportunities - Jammu Links News
How volatile is Vor Biopharma Inc. stock compared to the marketBuild a portfolio with strong long-term growth - Jammu Links News
What institutional investors are buying Vor Biopharma Inc. stockAchieve breakthrough investment performance - Jammu Links News
Why is Vor Biopharma Inc. stock attracting strong analyst attentionBuild wealth faster with expert stock picks - Jammu Links News
What catalysts could drive Vor Biopharma Inc. stock higher in 2025Navigate market volatility with smart strategies - Jammu Links News
What drives Vor Biopharma Inc. stock priceInvest smarter with expert trading signals - Jammu Links News
How does Vor Biopharma Inc. generate profit in a changing economyHigh-impact stock picks - Jammu Links News
What analysts say about Vor Biopharma Inc. stockRapid-fire capital growth - Jammu Links News
What makes Vor Biopharma Inc. stock price move sharplyCapitalize on market momentum for maximum gains - Jammu Links News
Is Vor Biopharma Inc. stock overvalued or undervaluedSignificant capital appreciation - Jammu Links News
How many analysts rate Vor Biopharma Inc. as a “Buy”Capitalize on fast-moving trading opportunities - Jammu Links News
What are the technical indicators suggesting about Vor Biopharma Inc.Rapid wealth creation - Jammu Links News
VOR SEC FilingsVor Biopharma Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Why Vor Biopharma Inc. stock attracts strong analyst attentionSwing Trading Plan With Smart Signals in Review - metal.it
Insiders the biggest winners as Vor Biopharma Inc.'s (NASDAQ:VOR) market cap rises to US$302m - simplywall.st
When is Vor Biopharma Inc. stock expected to show significant growth - jammulinksnews.com
Vor Biopharma (VOR) Jumps 10% on Addition of 2 CEOs to Board - MSN
These 10 Stocks are Winning Big - Insider Monkey
Vor Biopharma Shares Soar After Strategic Appointments in Leadership - StocksToTrade
Published on: 2025-07-28 13:58:09 - metal.it
What are analysts’ price targets for Vor Biopharma Inc. in the next 12 monthsGet timely alerts on market opportunities - Jammu Links News
Should I hold or sell Vor Biopharma Inc. stock in 2025Achieve breakthrough financial results - jammulinksnews.com
Does Vor Biopharma Inc. stock perform well during market downturnsMaximize your portfolio’s growth potential - Jammu Links News
What markets is Vor Biopharma Inc. expanding into Is DMAC stock a good long term investment option - jammulinksnews.com
What are the latest earnings results for Vor Biopharma Inc.Unlock real-time stock alerts for quick profits - Jammu Links News
How Efficient Is Vor Biopharma Inc. at Controlling Operating CostsDefensive Stock Picks with Upside - metal.it
Published on: 2025-07-27 20:45:01 - jammulinksnews.com
Published on: 2025-07-27 15:05:50 - jammulinksnews.com
How Vor Biopharma Inc. stock performs during market volatilityMarket Ready Callouts - metal.it
Is Vor Biopharma Inc. a good long term investmentOverwhelming profit margins - PrintWeekIndia
Vor Biopharma Inc. Stock Analysis and ForecastMassive profits - PrintWeekIndia
Vor Bio appoints Sandy Mahatme as CFO - MSN
보 바이오파마 (VOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):